skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Value of radioimmuno-assay of triiodothyronine and thyrotropic hormone in the diagnosis of thyroid disease (in German)

Journal Article · · Dtsch. Med. Wochenschr., v. 100, no. 15, pp. 805-812
OSTI ID:4132365

Results of a purely in-vitro test were compared with previously available methods in 425 patients. For triiodothyronine, a normal range must be differentiated from the so-called euthyroid range (0.8-2.0 ng/ml) for patients with euthyroid goitre. The accuracy for triiodothyronine is then more than 95% and in hyperthyroidism 97.5%. It is, therefore, superior to other in-vitro measurements. But a disadvantage is that it is easily influenced by thyroid and extrathyroid factors. Similar accuracy is obtained for the TRH function test (thyrotropine-releasing hormone). Notable is a 'negative' TRH test in 20% of patients with euthyroid goitre. The significance of triiodothyronine determination is decreased in autonomous adenoma, in which the TRH test has an accuracy of 96.5%. In rare diseases of the thyroid all diagnostic possibilities must be taken into account. In ordinary practice a stepwise course is suggested. RT$sub 3$U, T$sub 4$, T$sub 3$ and thyroid scan with sup(99m)Tc pertechnetate are useful as basic tests. PBI is still thought to be important. The second step involves the TRH test rather than $sup 131$I function test. Triiodothyronine determination is best for therapeutic and follow-up purposes, a situation in which TRH test is of limited value. (orig.)

Research Organization:
Goettingen Univ. (F.R. Germany). Medizinische Klinik und Poliklinik; (F.R. Germany). Radiologische Klinik und Poliklinik
NSA Number:
NSA-33-009679
OSTI ID:
4132365
Journal Information:
Dtsch. Med. Wochenschr., v. 100, no. 15, pp. 805-812, Other Information: 5 tabs.; 21 refs. Orig. Receipt Date: 30-JUN-76
Country of Publication:
Germany
Language:
German